Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$524K Sell
28,248
-89,027
-76% -$1.77M 0.11% 185
2026
Q1
$2.21M Buy
+117,275
New +$2.2M 0.28% 144
2025
Q1
Sell
-22,938
Closed -$335K 320
2024
Q4
$335K Buy
22,938
+2,635
+13% +$41.2K 0.09% 201
2024
Q3
$324K Buy
+20,303
New +$360K 0.1% 205
2021
Q4
Sell
-15,700
Closed -$225K 570
2021
Q3
$225K Buy
+15,700
New +$212K 0.06% 323
2021
Q1
Sell
-24,166
Closed -$372K 617
2020
Q4
$372K Buy
+24,166
New +$273K 0.08% 317
2019
Q2
Sell
-15,700
Closed -$440K 406
2019
Q1
$440K Buy
+15,700
New +$445K 0.16% 208

Other funds holding NOV

Sciencast Management's NOV Position: Q2 2026 in Review

Sciencast Management reduced its NOV (NOV) stake by 76% in Q2 2026, selling an estimated $1.77M and leaving 28,248 shares worth $524K. The position accounts for 0.11% of the portfolio, ranked #185.

Sciencast Management first reported a position in NOV in Q1 2019 and has held it in 7 quarters since. The position peaked at $2.21M in Q1 2026. 487 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Sciencast Management held 28,248 shares of NOV worth $524K as of Q2 2026.
  • Sciencast Management sold 89,027 NOV shares in Q2 2026, an estimated $1.77M.
  • NOV made up 0.11% of Sciencast Management's portfolio in Q2 2026, its #185 holding.
  • Sciencast Management first reported a position in NOV in Q1 2019 and has held it in 7 quarters since.
  • Sciencast Management's NOV position peaked at $2.21M in Q1 2026.
  • 487 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Sciencast Management's 13F filing for Q2 2026, filed 28 Jul 2026.